•Ravelin Properties REIT announced it does not expect to make principal or interest payments on its 9.00% convertible unsecured subordinated debentures.
•The maturity date for the 9% debentures is February 28, 2026.
•The REIT is internally managed and listed on the TSX under the symbol RPR.UN.
•The U.S. FDA approved BYSANTI (milsaperidone) as a first-line therapy for manic or mixed episodes associated with bipolar I disorder and for schizophrenia in adults.
•BYSANTI is a New Chemical Entity (NCE) that belongs to the class of atypical antipsychotics.
•TXNM Energy announced that the U.S. Federal Energy Regulatory Commission (FERC) has authorized the company's acquisition by Blackstone Infrastructure.
•The acquisition deal is valued at approximately $11.5 billion.
